Please login to the form below

Not currently logged in
Email:
Password:

triglycerides

This page shows the latest triglycerides news and features for those working in and with pharma, biotech and healthcare.

Amarin up as FDA speeds Vascepa’s cardiovascular claim review

Amarin up as FDA speeds Vascepa’s cardiovascular claim review

Vascepa (icosapent ethyl) is already approved to treat elevated triglycerides, a risk factor for heart disease, but could see its usage rise markedly if it also gets the new cardiovascular risk

Latest news

More from news
Approximately 1 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    aureus and Shigellosis. Corporate acquisition. 190. Amarin/ Eddingpharm. VASCEPA (icosapent ethyl) - triglyceride level reduction.

  • Pharma deals during May 2014 Pharma deals during May 2014

    One year ago AstraZeneca acquired Omthera. On May 7 Epanova, a soft gelation capsule containing Omega-3, was approved by the FDA as an adjunct to diet to reduce triglyceride levels

  • Pharma deals during November 2012 Pharma deals during November 2012

    a cash buyout valued at $845m. Pronova supplies the active ingredient in GSK's triglyceride lowering omega-3 drug Lovaza and, in addition, is developing competitor formulations – the most advanced being

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Channel purpose, change lives

    Ideas came to life through a multitude of means, from AstraZeneca’s talking fish who discuss "love, life and triglycerides" to Cancer Council NSW’s ‘I Touch Myself Project’ that reinvented

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics